While designing a group sequential clinical trial in the pharmaceutical industry setting, we often face a problem of determining the time for an interim analysis. For a two-stage trial we compute the sample sizes n and N per treatment group for the interim and final analyses. respectively, that mini
β¦ LIBER β¦
Optimal Spending Functions for Asymmetric Group Sequential Designs
β Scribed by Keaven M. Anderson
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 135 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0323-3847
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
SOME OPTIMAL AND NON-OPTIMAL TWO-STAGE D
β
H. I. PATEL
π
Article
π
1996
π
John Wiley and Sons
π
English
β 465 KB
π 1 views
Exact sequential tests for single sample
β
Nigel Stallard; Susan Todd
π
Article
π
2000
π
John Wiley and Sons
π
English
β 110 KB
Sequential tests are increasingly used to reduce the expected sample size of trials in medical research. The majority of such methods are based on the assumption of normality for test statistics. In clinical trials yielding a single sample of discrete data, that assumption is often poorly satisΓΏed.
Optimal sequential arrangement of evalua
β
Y. Perl; Y. Breitbart
π
Article
π
1976
π
Elsevier Science
π
English
β 526 KB
A Brief Review on Software Developments
β
Gernot Wassmer; Marc Vandemeulebroecke
π
Article
π
2006
π
John Wiley and Sons
π
English
β 87 KB
π 1 views
Optimal design of sequential experiments
β
V.G. DovΓ; A.P. Reverberi; L. Maga
π
Article
π
1993
π
Elsevier Science
π
English
β 425 KB
Stream function optimization for gradien
β
Dardo Tomasi
π
Article
π
2001
π
John Wiley and Sons
π
English
β 328 KB